TABLE 1.
Mouse genetic background | Cmax (μg/ml) | AUC (μg · h/ml) | T>MIC (h)b |
---|---|---|---|
TF3157 | 1.1 | 1.7 | 73, 36, 0 |
C57BL/6 | 0.03c | 0.05c | 0, 0, 0 |
TF 3157 DHP-I KO | 6.6 | 8.8 | 66, 49, 39 |
All groups were pretreated with probenecid (orally [p.o.] at 200 mg/kg). s.c., subcutaneous.
Results shown are for MICs 1 to 3, which are 230 ng/mol, 625 ng/mol, and 1,250 ng/mol, respectively. The time over MIC (T>MIC) was calculated taking as a reference the simulated profile of the compound after 3-times-a-day administration for 8 days, and simulation was extended to 200 h.
The concentration measured was close to the threshold of detection. The wild-type and DHP-I KO mouse strains corresponded to a TF3157 genetic background.